We are pleased to announce that Dr. Zhou has been invited by the National Institutes of Health (NIH) Center for Scientific Review (CSR) to serve as an Early Career Reviewer (ECR) for the Innovations in Nanosystems and Nanotechnology (INN) Study Section. The INN Study Section reviews innovative research applications in nanotechnology, biomaterials, drug and gene delivery, and related biomedical technologies.
This invitation recognizes Dr. Zhou’s expertise in RNA nanomedicine, targeted lipid nanoparticle (LNP) delivery, and nanotherapeutic development for lung inflammation and vascular disorders. Participation in the NIH Early Career Reviewer Program provides an opportunity to contribute to the NIH peer review process while gaining valuable experience in the evaluation of cutting-edge biomedical research proposals.
We are honored by this recognition and look forward to contributing to the NIH scientific review community.
We are pleased to welcome Tianyuan as a Summer Research Intern. Tianyuan is a second-year undergraduate student in Biomedical Engineering at the National University of Singapore, one of Asia’s leading research universities.
During her time in the lab, Tianyuan will participate in research projects focused on precision nanomedicine, RNA therapeutics, and lipid nanoparticle (LNP)-mediated drug and gene delivery. Through this experience, she will gain hands-on training in cutting-edge biomedical research and contribute to ongoing efforts to develop next-generation therapeutics for inflammatory and pulmonary diseases.
We are excited to have Tianyuan join our team and look forward to supporting her scientific growth and research development. We warmly welcome her to the Zhou Lab and wish her a productive, rewarding, and inspiring summer research experience.
Anton brings a strong passion for lung biology and nanomedicine, and we are thrilled to welcome him as he begins his doctoral training with us. As our inaugural PhD student, Anton will play a key role in shaping the scientific culture of the lab and contributing to our mission of developing innovative nano-therapeutic strategies for inflammatory lung diseases. We look forward to supporting his growth, celebrating his discoveries, and seeing the impact of his work in the years ahead. Welcome, Anton!!
We are thrilled to welcome our newest post-doc, Junfang, to our lab! Junfang brings her strong molecular biology expertise from Hong Kong Baptist University, and we look forward to seeing her contributions drive our research forward!
Welcome Lana and Anton - two fresh new additions to the Zhou Lab as rotation PhD students this fall quarter!